1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6422C6C289DBE073300258B35003D27D5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/global-medical-affairs-resourcing-benchmark-for-med-planning-functions?opendocument
18
19opendocument
203.235.182.206
21
22
23best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Structure, Staffing and Budgets

Global Medical Affairs Resourcing Benchmark for Med Planning Functions

ID: POP-383


Features:

6 Info Graphics

8 Data Graphics

80+ Metrics

4 Narratives


Pages: 19


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Optimized resource allocation within the Medical Planning function is imperative for aligning scientific initiatives with organizational objectives. By ensuring efficient resource utilization, companies can enhance productivity, prioritize key activities, manage risks, and ensure compliance, ultimately driving success in the highly competitive biopharma industry.

Recognizing the critical role of Medical Planning, Best Practices, LLC conducted benchmarking research to uncover valuable insights into how leading companies manage and optimize their Medical Planning approach and resources for maximum impact across the portfolio. The research probes the resourcing and capabilities of Medical Planning and Operations groups, assessing critical factors such as productivity, outsourcing benchmarks, spending, and staffing in mid-sized and large biopharma organizations.

The report further reveals best practices and lessons learned from top-performing organizations, providing a roadmap for others to refine their Medical Planning approaches.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Biotech; Consumer Products; Health Care; Clinical Research; Laboratories


Companies Profiled:
Acadia Pharmaceuticals; AbbVie; Agenus; Alexion Pharmaceuticals; Astellas; Boehringer Ingelheim; Dompé; Fidia; Gilead Sciences; Indivior; Novartis; Novo Nordisk; Organon; Pfizer; Pixacore; Protagonist Therapeutics; Prothena; Regeneron; Sandoz; Sanofi; Sobi; Takeda Pharmaceuticals; Teva Pharmaceuticals; UCB Pharma; United Therapeutics; Viatris

Study Snapshot

Best Practices, LLC engaged 30 Medical leaders from 26 leading mid-cap and large biopharma organizations in this research through a benchmarking survey.

Key topics covered in this report include:

  • Scope of Support
  • Productivity and Outsourced Capabilities
  • Medical Planning Spend and Staffing Levels
  • Project Management
  • Benefits of Outsourcing and Insourcing
  • Lessons Learned

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Scope of Medical Planning Support: Average total annual spend is $5.9 million (or ~$1 million per brand), with 34% going to outsourced activities.
  • Project Management: At roughly 4/5 of competitors, project managers are drawn directly from Medical Affairs – including Medical Planning.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 3-7
II.
Medical Planning Resourcing: Scope of Support, Staffing, Management & Lessons LearnedPg. 8-18
III.
About Best Practices, LLCPg. 19

    List of Charts & Exhibits

    I. Executive Summary

    • Research methodology and scope
    • Global Medical Planning study partner companies
    • Study summary for Medical Planning leadership
    • General findings for Global Medical Affairs resourcing and service delivery

    II. Medical Planning Resourcing: Scope of Support, Staffing, Management & Lessons Learned

    • Scope of Medical Planning support
    • Annual volume of Medical Planning execution across benchmark organizations
    • Extent of outsourcing within functions related to the strategic Medical Planning process
    • Staffing levels dedicated to each Medical Planning activity
    • Organizational source of Medical Planning project managers and the number of project management FTEs allocated to Medical Planning and vendor management
    • Benefits of an outsourced Medical Planning model
    • Benefits of an insourced Medical Planning model
    • Top lessons learned for outsourcing and insourcing Medical Planning capabilities
    • Current gaps in outsourced/insourced support and quantifying benefits of resourcing models
    • Geographic responsibility of the benchmark class